Intercontinental Exchange Other Income (Expense) increased by 235.7% to $232.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 250.6%, from -$154.00M to $232.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -28.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | -$54.00M | $1.23B | -$160.00M | -$130.00M | -$1.24B | -$300.00M | -$120.00M | -$108.00M | -$163.00M | -$409.00M | -$99.00M | -$205.00M | -$205.00M | -$172.00M | -$154.00M | -$165.00M | -$93.00M | -$171.00M | $232.00M |
| QoQ Change | — | -104.8% | >999% | -113.0% | +18.8% | -853.8% | +75.8% | +60.0% | +10.0% | -50.9% | -150.9% | +75.8% | -107.1% | +0.0% | +16.1% | +10.5% | -7.1% | +43.6% | -83.9% | +235.7% |
| YoY Change | — | — | — | — | -111.5% | <-999% | -124.4% | +25.0% | +16.9% | +86.9% | -36.3% | +17.5% | -89.8% | -25.8% | +57.9% | -55.6% | +19.5% | +54.6% | +0.6% | +250.6% |